NeuroSense Therapeutics Ltd. (NRSN) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$0.82
Day's range
$0.89

NeuroSense Therapeutics Ltd Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
UBS GROUP AG 08/13/2026 108.64 K $78.22 K   121.27% 0.43%
INDEPENDENT ADVISOR ALLIANCE 08/12/2026 100.00 K $72.00 K   100.00% 0.39%
YORKVILLE ADVISORS GLOBAL, LP 08/06/2026 78.00 K $56.16 K   0.00% 0.31%
COMMONWEALTH EQUITY SERVICES, LLC 07/29/2026 22.78 K $16.40 K   0.00% 0.09%
PNC FINANCIAL SERVICES GROUP, INC. 08/07/2026 21.15 K $15.23 K   0.00% 0.08%
PATHSTONE HOLDINGS, LLC 08/13/2026 16.53 K $11.90 K   0.00% 0.06%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 15.87 K $11.43 K   0.00% 0.06%
XTX TOPCO LTD 08/14/2026 11.47 K $8.26 K   100.00% 0.05%
CREATIVE PLANNING 08/13/2026 11.41 K $8.22 K   -4.21% 0.04%
HRT FINANCIAL LP 08/14/2026 10.52 K $7.00 K   100.00% 0.04%
JONES FINANCIAL COMPANIES LLLP 08/14/2026 1.00 K $757   0.00% 0.00%
SBI SECURITIES CO., LTD. 07/23/2026 255 $184   -3.77% 0.00%
TWO SIGMA INVESTMENTS, LP 08/14/2026 0 $0   -100.00% 0.00%
MEITAV INVESTMENT HOUSE LTD 07/20/2026 0 $0   -100.00% 0.00%
JANE STREET GROUP, LLC 08/14/2026 0 $0   -100.00% 0.00%

NeuroSense Therapeutics Ltd institutional Ownership - FAQ's

During the previous two years, 15 institutional investors and hedge funds held shares of NeuroSense Therapeutics Ltd. The most heavily invested institutionals were:

UBS Group AG: 108,636

Independent Advisor Alliance: 100,000

Yorkville Advisors Global, LP: 78,000

COMMONWEALTH EQUITY SERVICES, LLC: 22,775

PNC FINANCIAL SERVICES GROUP, INC.: 21,150

Pathstone Holdings, LLC: 16,528

1.56% of NeuroSense Therapeutics Ltd stock is owned by institutional investors.

Institutional investors have bought a total of 397.61 K shares in the last 24 months. This purchase volume represents approximately $333.99 K in transactions.